Home›Companies›Biotech & Pharma›CancerVAX

CancerVAX, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 18, 2024·Suggest an edit

About CancerVAX

CancerVAX is a private company based in Santa Barbara, California, incorporated in 2021 in Nevada. It has reported $1,000,000 raised in one offering on Form D since October 2023. Its chief executive is Byron Elton.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 13, 2023Oct 26, 2023amended Oct 18, 2024$1,000,000of $10.0M target1$1.0MEquityRule 506(c)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CancerVAX's Form D filed Oct 18, 2024.

CM
Carla Miller
Director
BE
Byron Elton
CEO and director

Sources

  1. SECCancerVAX, Inc. Form D, filed Oct 26, 2023
  2. SECCancerVAX, Inc. filing history